Vasomedical, Inc. - EECP® Therapy

What's New

News & Events

2010
July
7/29		VasoHealthcare Holds Launch Summit 2010 In Greensboro, NC
7/20		Vasomedical Releases iPhone Application for EECP^® Therapy

June
6/29		Vasomedical Announces Reorganization of Its Board of Directors

May
5/24		Vaso Healthcare, a Subsidiary of Vasomedical, Inc. Signs Exclusive Sales Representative Agreement with GE Healthcare

Apr
4/9		Vasomedical Announces FDA 510(k) Clearance on the First Combined ECG Holter and Ambulatory Blood Pressure Monitoring System

Mar
3/22		Vasomedical Makes An Impact At The ACC Scientific Sessions 2010

Feb
2/12		Vasomedical, Inc. Donates 1,096 Pounds Of Food/Household Goods To The LI Cares Food Bank

2009
Dec
12/9		EECP Newsletter - EECP® As An Effective Treatment Of Heart Failure - Volume 2, Issue 2

Nov
11/19		Vasomedical Launches New Products at the AHA Scientific Sessions 2009

Oct
10/30		EECP® Therapy Symposium at the Great Wall ICC 2009
10/21		Vasomedical Reports Profit First Quarter Fiscal Year 2010 Financial Results

Sep
9/1		Multiple Presentations at the European Society of Cardiology Congress Document EECP Promotes Coronary Collateral Flow Leading to Sustained Clinical Improvement

Aug
8/27		Abstracts from the 2009 European Society of Cardiology (ESC) Congress
		#2818: Direct Evidence for Therapeutic induction of arteriogenesis is Patients with Stable Angina Pectoris via External Counterpulsation: A Prospective Controlled Proof of Concept Trial
		#4519: Angina Class is Correlated with DASI Score in End Stage, Refractory Angina Patients
		#4521: Sustained Symptomatic Benefit of Enhanced External Counterpulsation (EECP) Therapy in Patients With Chronic Refractory Angina
		#4757: Regulation of Myocardial Perfusion at High Perfusion Pressure During External Counterpulsation

July
7/2		Improvement of Fractional Flow Reserve and Collateral Flow by Treatment with External Counterpulsation (Art.Net.-2 Trial), Eur J Clin Invest.

June
6/16		Assessment of the Effect of External Counterpulsation on Myocardial Adaptive Arteriogenesis by Invasive Functional Measurements - Design of the Arteriogenesis Network Trial 2, Int J Cardiol.
6/3		Old Angina Therapy New Again

May
5/16		Invasive Left Ventricular Energetics During EECP, Am J Ther.
5/15		EECP Newsletter - Repeat Treatment with EECP Therapy - Volume 2, Issue 1
5/		ACCEL: Interview with Dr. Ozlem Soran (ACC members)
5/9		How Wonderpants Cured My Angina and Gave Me My Life Back

Apr
4/13		Enhanced External Counterpulsation for the Treatment of Stable Angina and Heart Failure: A Systematic Review and Economic Analysis, Health Technol Asses.
4/6		Vasomedical Introduces BIOX Holter Monitoring Systems and Analysis Software

Mar
3/16		Effect of Enhanced External Counterpulsation on Clinical Symptoms, Quality of Life, 6-Minute Walking Distance, and Echocardiographic Measurements of Left Ventricular Systolic and Diastolic Function After 35 Days of Treatment and at 1-Year Follow Up in 47 Patients With Chronic Refractory Angina Pectoris, Am J Ther.
3/1		Enhanced External Counterpulsation: An Innovative Physical Therapy for Refractory Angina, PM R.
3/1		Results of Two Randomized Controlled Studies on Vasomedical EECP Therapy Presented at the American College of Cardiology (ACC) 58th Annual Scientific Session

Feb
2/		EECP: A Non-invasive Therapy for Refractory Angina
2/18		World Renowned Oxymed Hospitals Chennai Signed an Agreement with Cambridge University, UK for Joint Study of Arteria
2/		Treatment Options for Refractory Angina Pectoris, Curr Treat Options Cardiovasc Med.

Jan
1/		New Forum Launched for EECP Therapy Patients and Medical Professionals -- www.EECPforum.com

2008
Dec
12/29		Management of Patients with Cardiac Syndrome X, Int J Cardiol.
12/18		Two Year Outcome and Baseline Factors Associated with Treatment Failure, BMC Cardiovasc Disord.
12/		EECP Therapy Improves Systolic Blood Pressure, Am Heart J.
12/		Comparison of Patients Undergoing Enhanced External Counterpulsation and Spinal Cord Stimulation for Refractory Angina Pectoris, Coron Artery Dis.

Nov
11/		New Data Presented at the AHA Scientific Sessions 2008
11/		Ancillary Services for Cardiology, Medscape

Events & Presentations

ESC - European Society of Cardiology Congress
August 28- September 2, 2010
Stockholm, Sweden
Exhibit: C18:63

ACC - American College Of Cardiology Scientfic Sessions
March 13-17, 2010
Atlanta, Georgia, U.S.A.
Exhibit Booth: #1852

Heart Failure Dubai 2010
February 18-20, 2010
Festival City, Dubai

PRESENTATIONS:

September 1
Posters - Zone 3
Poster Session 6: Stable Coronary Artery Disease. An Ongoing Challenge.
Time: 14:00 (2:00 p.m.)

No.: 4519
Angina Class is Correlated with DASI Score in End Stage, Refractory Angina Patients
E Kennard (Pittsburgh, US)

No.: 4521
Sustained Symptomatic Benefit of Enhanced External Counterpulsation (EECP) Therapy in Patients with Chronic Refractory Angina
C A Morley (Bradford, GB)

No.: 4757
Regulation of Myocardial Perfusion at High Perfusion Pressure During External Counterpulsation
S F de Marchi (Berne, CH)

Press Releases

Vasomedical Releases iPhone Application for EECP^® Therapy >

Vasomedical Announces Reorganization of Its Board of Directors >

Vaso Healthcare, a Subsidiary of Vasomedical, Inc. Signs Exclusive Sales Representative Agreement with GE Healthcare >

Vasomedical Announces FDA 510(k) Clearance on the First Combined ECG Holter and Ambulatory Blood Pressure Monitoring System >